Form 8-K - Current report:
SEC Accession No. 0001104659-23-107241
Filing Date
2023-10-05
Accepted
2023-10-05 17:00:20
Documents
12
Period of Report
2023-10-05
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327120d3_8k.htm   iXBRL 8-K 27122
  Complete submission text file 0001104659-23-107241.txt   199123

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fold-20231005.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20231005_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20231005_pre.xml EX-101.PRE 22379
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2327120d3_8k_htm.xml XML 3204
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 231312075
SIC: 2834 Pharmaceutical Preparations